SLU-PP-332 (250mcg)

Research Compound for Metabolic & Mitochondrial Signalling

Alpha Lab SLU‑PP‑332 is a research‑grade small molecule designed for laboratory investigation into cellular energy metabolism, mitochondrial function, and metabolic signalling. SLU‑PP‑332 acts as an agonist of oestrogen‑related receptors (ERRs), a class of nuclear receptors involved in the regulation of oxidative metabolism, fatty acid oxidation, and transcriptional control of energy‑related genes. 

Main Research Benefits of SLU‑PP‑332

• Supports research into mitochondrial biogenesis and cellular respiration pathways
• Investigates metabolic regulation and fatty acid oxidation mechanisms
• Useful for studies involving endurance‑like signalling and energy expenditure
• Explores nuclear receptor (ERR) activation and downstream gene transcription

SLU‑PP‑332 is frequently used by researchers focused on metabolic health, cellular energy regulation, and systems that mimic aspects of **exercise‑induced metabolic adaptations** in preclinical settings. 

How SLU‑PP‑332 Works (Research Mechanism)

Alpha Labs SLU‑PP‑332 is a synthetic small molecule that functions as a **pan‑agonist of oestrogen‑related receptors (ERRα, ERRβ, ERRγ)**, with preferential potency toward ERRα. When bound, these receptors act as transcription factors that regulate genes involved in mitochondrial function, fatty acid uptake, and oxidative phosphorylation. Activation of ERR pathways is associated with increased cellular energy production, enhanced mitochondrial biogenesis, and shifts toward fat utilisation in laboratory models. 

Unlike classical oestrogen receptors, ERRs do not bind oestrogen but play a key regulatory role in energy homeostasis. By engaging ERR pathways, SLU‑PP‑332 offers a tool for investigating how metabolic and mitochondrial signalling networks influence cellular energy balance and endurance‑related processes. 

Product Features & Specifications

• Brand: Alpha Labs
• Compound: SLU‑PP‑332 (small molecule ERR agonist)
• Form: Capsules (usually 500 mcg per capsule) 
• Use: Laboratory and scientific research only
• Quality: Premium‑grade research chemical

Suggested Research Usage

In controlled laboratory environments, SLU‑PP‑332 is typically administered according to the goals of the experimental protocol. Research often explores its effects on **metabolic gene expression, cellular respiration, and pathways linked to oxidative metabolism**. Dosing and study design should align with your research’s objectives and safety standards.

⚠️ Important: Alpha Labs SLU‑PP‑332 is intended strictly for research use. It is not approved as a dietary supplement, therapeutic, or for human or veterinary consumption. Always follow applicable legal regulations and laboratory safety protocols when handling research chemicals.

Frequently Asked Questions

What is SLU‑PP‑332?

SLU‑PP‑332 is a synthetic research compound that acts as an **agonist of oestrogen‑related receptors (ERRα, ERRβ, ERRγ)**, which are involved in regulating metabolic and mitochondrial gene expression in cells. 

Why do researchers use SLU‑PP‑332?

Researchers investigate SLU‑PP‑332 to understand how ERR‑mediated signalling affects energy metabolism, mitochondrial activity, fat oxidation, and exercise‑like metabolic responses at the molecular level. 

How does SLU‑PP‑332 differ from PPAR agonists like Cardarine?

While competitors of SLU‑PP‑332 typically act as PPAR agonists (mainly targeting PPARδ) to modulate lipid metabolism, SLU‑PP‑332 instead targets oestrogen‑related receptors (ERRs) — nuclear receptors that play a broader role in regulating mitochondrial biogenesis, oxidative metabolism, and overall energy homeostasis.

Is SLU‑PP‑332 approved for human use?

No — SLU‑PP‑332 is strictly a **research chemical** and is not approved by regulatory bodies for human or veterinary use. It should only be used under controlled laboratory conditions. 

Explore advanced metabolic and mitochondrial research pathways with Alpha Labs SLU‑PP‑332 — a specialized ERR agonist designed for scientific investigation into energy regulation, oxidative metabolism, and exercise‑associated signalling.